Evidence map›Paper›PMID 22745195›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2012

Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function.

Ana Paula Abreu, Sekoni D Noel, Shuyun Xu, Rona S Carroll, Ana Claudia Latronico, Ursula B Kaiser

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Additional mutation inBMJ case reports · 2024
    Article
  3. Review
  4. Article
  5. Trafficking-defective mutant PROKR2 cycles between endoplasmic reticulum and Golgi to attenuate endoplasmic reticulum stress.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Endocrine connections · 2017
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Fertility and fragrance: another cause of Kallmann syndrome.The Journal of clinical investigation · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ana Paula AbreuDivision of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Sekoni D Noel
Shuyun Xu
Rona S Carroll
Ana Claudia Latronico
Ursula B Kaiser
Brigham and Women's Hospital · USHarvard University · USUniversidade de São Paulo · BR

Funding

The Genetic Determinants of Human GNRH DeficiencyU54HD028138 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI SEMINARA, STEPHANIE BETH · 2000 to 2013
$19.9M
Exploring the Role of the Prokineticin System in Human ReproductionF05HD072773 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI METZGER, ANA PAULA DE ABREU E SILVA · 2012 to 2014
$192k
NICHD NIH HHS F05 HD072773NICHD NIH HHS U54 HD028138NICHD NIH HHS U54 HD28138
6 · The paper itself

Abstract

Prokineticin receptors (PROKR) are G protein-coupled receptors (GPCR) that regulate diverse biological processes, including olfactory bulb neurogenesis and GnRH neuronal migration. Mutations in PROKR2 have been described in patients with varying degrees of GnRH deficiency and are located in diverse functional domains of the receptor. Our goal was to determine whether variants in the first intracellular loop (ICL1) of PROKR2 (R80C, R85C, and R85H) identified in patients with hypogonadotropic hypogonadism interfere with receptor function and to elucidate the mechanisms of these effects. Because of structural homology among GPCR, clarification of the role of ICL1 in PROKR2 activity may contribute to a better understanding of this domain across other GPCR. The effects of the ICL1 PROKR2 mutations on activation of signal transduction pathways, ligand binding, and receptor expression were evaluated. Our results indicated that the R85C and R85H PROKR2 mutations interfere only modestly with receptor function, whereas the R80C PROKR2 mutation leads to a marked reduction in receptor activity. Cotransfection of wild-type (WT) and R80C PROKR2 showed that the R80C mutant could exert a dominant negative effect on WT PROKR2 in vitro by interfering with WT receptor expression. In summary, we have shown the importance of Arg80 in ICL1 for PROKR2 expression and demonstrate that R80C PROKR2 exerts a dominant negative effect on WT PROKR2.

Indexed as

Amino Acid MotifsAnimalsBinding, CompetitiveChlorocebus aethiopsCOS CellsGastrointestinal HormonesGene ExpressionGenes, DominantGlycosylationHEK293 CellsHumansHypogonadismInositol PhosphatesMutation, MissenseNeuropeptidesProtein BindingGastrointestinal HormonesInositol PhosphatesNeuropeptidesPROK2 protein, humanPROKR2 protein, humanReceptors, G-Protein-CoupledReceptors, Peptide

Identifiers

PMID22745195
PMCPMC3404297
OpenAlexW2107527671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.